Latest News and Press Releases
Want to stay updated on the latest news?
-
14. april 2026 Meddelelse nr. 9 Tildeling af Warrants København, Danmark, den 14. april 2026 (GLOBE NEWSWIRE)...
-
April 14, 2026 Announcement no. 9 Grant of Warrants ...
-
13. april 2026 Meddelelse nr. 8 Storaktionær Meddelelse KØBENHAVN, DANMARK og BOSTON, MA, USA, 13. april 2026 – BioPorto A/S (“BioPorto” eller “Selskabet”) (CPH: BIOPOR) offentliggør hermed, i...
-
April 13, 2026 Company Announcement No. 8 Major Shareholder Announcement COPENHAGEN, DENMARK and BOSTON, MA, USA, 13 April 2026 – BioPorto A/S (“BioPorto” or the “Company”) (CPH: BIOPOR) hereby...
-
8. april 2026 Meddelelse nr. 7 BioPorto frasælger antistofforretning til Janel Life Sciences, LLC KØBENHAVN, DANMARK og BOSTON, MA, USA, 8. april, 2026 – BioPorto A/S ("BioPorto" eller "Selskabet")...
-
April 8, 2026 Company Announcement No. 7 BioPorto Successfully Completes Divestment of its Antibody Business to Janel Life Sciences, LLC COPENHAGEN, DENMARK and BOSTON, MA, USA, April 8, 2026 –...
-
31. marts, 2026Meddelelse no. 6 BioPorto indsender anmodning om FDA pre‑submission for amerikansk voksenprogram for urin‑NGAL efter positiv EPACRA‑analyse af AKI‑cut‑off KØBENHAVN, DANMARK, 31....
-
March 31, 2026Announcement no. 6 BioPorto Advances U.S. Adult Urine NGAL Program with FDA Pre-Submission Request After Positive EPACRA AKI Cut Off Analysis COPENHAGEN, DENMARK, 31 March 2026 –...
-
31. marts 2026 Presse Meddelelse KDIGO offentliggør udkast til klinisk praksis guideline 2026 for akut nyreskade og akut nyresygdom KØBENHAVN, DANMARK, 31. marts 2026 – BioPorto A/S (“BioPorto”...
-
March 31, 2026News Release KDIGO publishes 2026 Clinical Practice Guideline Draft for Acute Kidney Injury and Acute Kidney Disease COPENHAGEN, DENMARK, 31 March 2026 – BioPorto A/S (“BioPorto” or...